GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (TSX:IN) » Definitions » Price-to-Tangible-Book

InMed Pharmaceuticals (TSX:IN) Price-to-Tangible-Book : 2.00 (As of Apr. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is InMed Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-04-26), InMed Pharmaceuticals's share price is C$4.19. InMed Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$2.09. Hence, InMed Pharmaceuticals's Price to Tangible Book Ratio of today is 2.00.

The historical rank and industry rank for InMed Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

TSX:IN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.13   Med: 3.7   Max: 196.19
Current: 0.16

During the past 13 years, InMed Pharmaceuticals's highest Price to Tangible Book Ratio was 196.19. The lowest was 0.13. And the median was 3.70.

TSX:IN's Price-to-Tangible-Book is ranked better than
99.18% of 1220 companies
in the Biotechnology industry
Industry Median: 2.68 vs TSX:IN: 0.16

A closely related ratio is called PB Ratio. As of today, InMed Pharmaceuticals's share price is C$4.19. InMed Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$2.45. Hence, InMed Pharmaceuticals's P/B Ratio of today is 1.71.


InMed Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for InMed Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Price-to-Tangible-Book Chart

InMed Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.30 6.90 - - -

InMed Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InMed Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, InMed Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InMed Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InMed Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where InMed Pharmaceuticals's Price-to-Tangible-Book falls into.



InMed Pharmaceuticals Price-to-Tangible-Book Calculation

InMed Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=4.19/2.09
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


InMed Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


InMed Pharmaceuticals (TSX:IN) Business Description

Traded in Other Exchanges
Address
815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (TSX:IN) Headlines

No Headlines